Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer’s diseaseJunqiu He, Kin Yip Tam|Drug Discovery Today|2024Cited by 15
Pharmacological interventions on GSK3β phosphorylation-mediated tau aggregation by modulating phase separation of tau proline-rich domainShan Sun, Zheng Ying, Junqiu He et al.|Biomedicine & Pharmacotherapy|2025Cited by 3
Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer's diseaseRong Wei, Kin Yip Tam, Junqiu He et al.|Neuroscience Letters|2023Cited by 1
Triple-Target Inhibition of Cholinesterase, Amyloid Aggregation, and GSK3β to Ameliorate Cognitive Deficits and Neuropathology in the Triple-Transgenic Mouse Model of Alzheimer’s DiseaseJunqiu He, Kin Yip Tam, Hongfeng Wang et al.|Neuroscience Bulletin|2025Cited by 1
Current mouse models of Alzheimer’s disease for investigating therapeutic agentsJunqiu He, Kin Yip Tam|Elsevier eBooks|2022Cited by 0